Literature DB >> 31177474

N-doped carbon nanodots@UiO-66-NH2 as novel nanoparticles for releasing of the bioactive drug, rosmarinic acid and fluorescence imaging.

Khalil Tabatabaeian1, Masoomeh Simayee2, Abdollah Fallah-Shojaie2, Farhad Mashayekhi3.   

Abstract

BACKGROUND AND THE PURPOSE OF THE STUDY: The purpose of the present research was to synthesize affordable nanoparticles for simultaneous drug release and cell fluorescence imaging to decrease the costs associated with conventional treatments.
METHODS: In the present study, N-doped carbon nanodots@UiO-66-NH2 nanoparticles were simply synthesized in few steps and were used as a novel carrier for rosmarinic acid (RA). Nano particles were characterized by FT-IR spectroscopy, X-ray powder diffraction (XRD), Dynamic Light Scattering (DLS) and field emission scanning electron microscopy (FE-SEM). UV/vis spectroscopy was used to study the release profile of RA drug from this novel carrier. Methylthiazolyl tetrazolium (MTT) assay was to evaluate the effect of irradiation with a (UV) lamp. Confocal laser scanning microscopy was used for fluorescence imaging of cancer cells.
RESULTS: Results of the MTT assay revealed that UiO-66-NH2@N-CNDs nanoparticles as a drug carrier for RA, have an excellent therapeutic effect due to their high quantum yield under irradiation of UV light. On the contrary, the observed therapeutic effect was decreased under ambient light.
CONCLUSIONS: UiO-66-NH2@N-CNDs nanoparticles can be considered as promising vehicles for drug delivery due to their cost effectiveness in cancer treatment, based on the results of MTT assay. It should be emphasized that this nanocarrier can be as potential platforms for coincident drug delivery system and cell fluorescence imaging due to possessing green fluorescence and microporosity features. Graphical abstract Graphical abstract.

Entities:  

Keywords:  Drug delivery; N-doped carbon nanodot; Rosmarinic acid; Therapeutic effect; UiO-66-NH2

Mesh:

Substances:

Year:  2019        PMID: 31177474      PMCID: PMC6592999          DOI: 10.1007/s40199-019-00276-1

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  31 in total

1.  HIV integrase inhibitory activity of Agastache rugosa.

Authors:  H K Kim; H K Lee; C G Shin; H Huh
Journal:  Arch Pharm Res       Date:  1999-10       Impact factor: 4.946

2.  ["Tannins" and derivatives of hydroxycinnamic acid in labiatae (author's transl)].

Authors:  V I Litvinenko; T P Popova; A V Simonjan; I G Zoz; V S Sokolov
Journal:  Planta Med       Date:  1975-06       Impact factor: 3.352

3.  Crystal engineering of NLO materials based on metal--organic coordination networks.

Authors:  Owen R Evans; Wenbin Lin
Journal:  Acc Chem Res       Date:  2002-07       Impact factor: 22.384

Review 4.  Ordered porous materials for emerging applications.

Authors:  Mark E Davis
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

5.  Quantum-sized carbon dots for bright and colorful photoluminescence.

Authors:  Ya-Ping Sun; Bing Zhou; Yi Lin; Wei Wang; K A Shiral Fernando; Pankaj Pathak; Mohammed Jaouad Meziani; Barbara A Harruff; Xin Wang; Haifang Wang; Pengju G Luo; Hua Yang; Muhammet Erkan Kose; Bailin Chen; L Monica Veca; Su-Yuan Xie
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

Review 6.  Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.

Authors:  M R al-Sereiti; K M Abu-Amer; P Sen
Journal:  Indian J Exp Biol       Date:  1999-02       Impact factor: 0.818

7.  Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.

Authors:  M A Kelm; M G Nair; G M Strasburg; D L DeWitt
Journal:  Phytomedicine       Date:  2000-03       Impact factor: 5.340

8.  Inhibitory effects of rosmarinic acid on the proliferation of cultured murine mesangial cells.

Authors:  T Makino; T Ono; E Muso; H Yoshida; G Honda; S Sasayama
Journal:  Nephrol Dial Transplant       Date:  2000-08       Impact factor: 5.992

Review 9.  Metal-based antitumour drugs in the post genomic era.

Authors:  Paul J Dyson; Gianni Sava
Journal:  Dalton Trans       Date:  2006-03-28       Impact factor: 4.390

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

View more
  1 in total

Review 1.  Metal-Organic Frameworks for Bioimaging: Strategies and Challenges.

Authors:  Yanfei Liu; Ting Jiang; Zhenbao Liu
Journal:  Nanotheranostics       Date:  2022-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.